Restenosis after renal artery angioplasty and stenting: Incidence and risk factors

Journal of Vascular Surgery

Volumn 50, Issue 4, 2009, Pages

  Corriere, Matthew A ^a   Edwards, Matthew S ^a   Pearce, Jeffrey D ^a   Andrews, Jeanette S ^a   Geary, Randolph L ^a   Hansen, Kimberley J ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RENAL ARTERY; RESTENOSIS; STENT; SURVIVAL RATE;

AGE DISTRIBUTION; AGED; ANGIOGRAPHY; ANGIOPLASTY; CONFIDENCE INTERVALS; FEMALE; FOLLOW-UP STUDIES; GRAFT OCCLUSION, VASCULAR; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROBABILITY; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RENAL ARTERY OBSTRUCTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; STENTS; SURVIVAL RATE; TIME FACTORS; ULTRASONOGRAPHY, DOPPLER, DUPLEX; VASCULAR PATENCY;

EID: 70349332958     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2009.05.019     Document Type: Article

References (29)

1. Edwards M.S., Craven T.E., Burke G.L., Dean R.H., and Hansen K.J. Renovascular disease and the risk of adverse coronary events in the elderly: a prospective, population-based study. Arch Intern Med 165 (2005) 207-213
2. Leertouwer T.C., Gussenhoven E.J., Bosch J.L., van Jaarsveld B.C., van Dijk L.C., Deinum J., et al. Stent placement for renal arterial stenosis: where do we stand? A meta-analysis. Radiology 216 (2000) 78-85
3. Baumgartner I., von Aesch K., Do D.D., Triller J., Birrer M., and Mahler F. Stent placement in ostial and nonostial atherosclerotic renal arterial stenoses: a prospective follow-up study. Radiology 216 (2000) 498-505
4. Dorros G., Jaff M., Jain A., Dufek C., and Mathiak L. Follow-up of primary Palmaz-Schatz stent placement for atherosclerotic renal artery stenosis. Am J Cardiol 75 (1995) 1051-1055
5. Lederman R.J., Mendelsohn F.O., Santos R., Phillips H.R., Stack R.S., and Crowley J.J. Primary renal artery stenting: characteristics and outcomes after 363 procedures. Am Heart J 142 (2001) 314-323
6. Nolan B.W., Schermerhorn M.L., Powell R.J., Rowell E., Fillinger M.F., Rzucidlo E.M., et al. Restenosis in gold-coated renal artery stents. J Vasc Surg 42 (2005) 40-46
7. Nolan B.W., Schermerhorn M.L., Rowell E., Powell R.J., Fillinger M.F., Rzucidlo E.M., et al. Outcomes of renal artery angioplasty and stenting using low-profile systems. J Vasc Surg 41 (2005) 46-52
8. Tullis M.J., Zierler R.E., Glickerman D.J., Bergelin R.O., Cantwell-Gab K., and Strandness Jr. D.E. Results of percutaneous transluminal angioplasty for atherosclerotic renal artery stenosis: a follow-up study with duplex ultrasonography. J Vasc Surg 25 (1997) 46-54
9. Bates M.C., Rashid M., Campbell J.E., Stone P.A., Broce M., and Lavigne P.S. Factors influencing the need for target vessel revascularization after renal artery stenting. J Endovasc Ther 13 (2006) 569-577
10. Vignali C., Bargellini I., Lazzereschi M., Cioni R., Petruzzi P., Caramella D., et al. Predictive factors of in-stent restenosis in renal artery stenting: a retrospective analysis. Cardiovasc Intervent Radiol 28 (2005) 296-302
11. Kane G.C., Hambly N., Textor S.C., Stanson A.W., and Garovic V.D. Restenosis following percutaneous renal artery revascularization. Nephron Clin Pract 107 (2007) c63-c69
12. Shammas N.W., Kapalis M.J., Dippel E.J., Jerin M.J., Lemke J.H., Patel P., et al. Clinical and angiographic predictors of restenosis following renal artery stenting. J Invasive Cardiol 16 (2004) 10-13
13. Edwards M.S., Craven B.L., Stafford J., Craven T.E., Sauve K.J., Ayerdi J., et al. Distal embolic protection during renal artery angioplasty and stenting. J Vasc Surg 44 (2006) 128-135
14. Corriere M.A., Pearce J.D., Edwards M.S., Stafford J., and Hansen K.J. Endovascular management of atherosclerotic renal artery stenosis: early results following primary intervention. J Vasc Surg 48 (2008) 580-587
15. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
16. Radermacher J., Chavan A., Bleck J., Vitzthum A., Stoess B., Gebel M.J., et al. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med 344 (2001) 410-417
17. Hansen K.J., Tribble R.W., Reavis S.W., Canzanello V.J., Craven T.E., Plonk Jr. G.W., et al. Renal duplex sonography: evaluation of clinical utility. J Vasc Surg 12 (1990) 227-236
18. Bakker J., Beutler J.J., Elgersma O.E., de Lange E.E., de Kort G.A., and Beek F.J. Duplex ultrasonography in assessing restenosis of renal artery stents. Cardiovasc Intervent Radiol 22 (1999) 475-480
19. Napoli V., Pinto S., Bargellini I., Vignali C., Cioni R., Petruzzi P., et al. Duplex ultrasonographic study of the renal arteries before and after renal artery stenting. Eur Radiol 12 (2002) 796-803
20. Parenti G.C., Palmarini D., Bilzoni M., Campioni P., Mannella P., and Ginevra A. Role of color-Doppler sonography in the follow-up of renal artery stenting. Radiol Med (Torino) 113 (2008) 242-248
21. Motew S.J., Cherr G.S., Craven T.E., Travis J.A., Wong J.M., Reavis S.W., et al. Renal duplex sonography: main renal artery versus hilar analysis. J Vasc Surg 32 (2000) 462-469
22. Kastrati A., Schomig A., Elezi S., Schuhlen H., Dirschinger J., Hadamitzky M., et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol 30 (1997) 1428-1436
23. Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation 109 23 suppl 1 (2004) III39-III43
24. Calabro P., and Yeh E.T. The pleiotropic effects of statins. Curr Opin Cardiol 20 (2005) 541-546
25. Cheung C.M., Patel A., Shaheen N., Cain S., Eddington H., Hegarty J., et al. The effects of statins on the progression of atherosclerotic renovascular disease. Nephron Clin Pract 107 (2007) c35-c42
26. Erl W., Hristov M., Neureuter M., Yan Z.Q., Hansson G.K., and Weber P.C. HMG-CoA reductase inhibitors induce apoptosis in neointima-derived vascular smooth muscle cells. Atherosclerosis 169 (2003) 251-258
27. Erl W. Atorvastatin-induced downregulation of survivin and vascular smooth muscle cell apoptosis: a causal relationship in restenosis?. Cardiovasc Drugs Ther 21 (2007) 141-144
28. Crisby M., Nordin-Fredriksson G., Shah P.K., Yano J., Zhu J., and Nilsson J. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation 103 (2001) 926-933
29. Heeneman S., Sluimer J.C., and Daemen M.J. Angiotensin-converting enzyme and vascular remodeling. Circ Res 101 (2007) 441-454